393 related articles for article (PubMed ID: 23635878)
1. Management of neuropathic pain in children with cancer.
Friedrichsdorf SJ; Nugent AP
Curr Opin Support Palliat Care; 2013 Jun; 7(2):131-8. PubMed ID: 23635878
[TBL] [Abstract][Full Text] [Related]
2. Neuropathic pain in children with cancer.
Jacob E
J Pediatr Oncol Nurs; 2004; 21(6):350-7. PubMed ID: 15475472
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management.
Taverner T
Int J Palliat Nurs; 2015 Aug; 21(8):380-4. PubMed ID: 26312533
[TBL] [Abstract][Full Text] [Related]
4. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
5. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature.
Vadalouca A; Raptis E; Moka E; Zis P; Sykioti P; Siafaka I
Pain Pract; 2012 Mar; 12(3):219-51. PubMed ID: 21797961
[TBL] [Abstract][Full Text] [Related]
7. Oxycodone and the challenge of neuropathic cancer pain: a review.
Núñez Olarte JM
Oncology; 2008; 74 Suppl 1():83-90. PubMed ID: 18758204
[TBL] [Abstract][Full Text] [Related]
8. [New data for the pathomechanism of neuropathic pain: therapeutic evidences].
Tajti J; Szok D; Vécsei L
Neuropsychopharmacol Hung; 2013 Mar; 15(1):13-7. PubMed ID: 23542755
[TBL] [Abstract][Full Text] [Related]
9. Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in national clinical practice guidelines from European countries.
Piano V; Verhagen S; Schalkwijk A; Hekster Y; Kress H; Lanteri-Minet M; Burgers J; Treede RD; Engels Y; Vissers K
Pain Pract; 2014 Jan; 14(1):1-7. PubMed ID: 23360414
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society - part one.
Szczudlik A; Dobrogowski J; Wordliczek J; Stępień A; Krajnik M; Leppert W; Woroń J; Przeklasa-Muszyńska A; Kocot-Kępska M; Zajączkowska R; Janecki M; Adamczyk A; Malec-Milewska M
Neurol Neurochir Pol; 2014; 48(4):262-71. PubMed ID: 25168326
[TBL] [Abstract][Full Text] [Related]
11. Experience with gabapentin for neuropathic pain in adolescents: report of five cases.
Butkovic D; Toljan S; Mihovilovic-Novak B
Paediatr Anaesth; 2006 Mar; 16(3):325-9. PubMed ID: 16490100
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial.
Keskinbora K; Pekel AF; Aydinli I
J Pain Symptom Manage; 2007 Aug; 34(2):183-9. PubMed ID: 17604592
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.
Moisset X; Bouhassira D; Avez Couturier J; Alchaar H; Conradi S; Delmotte MH; Lanteri-Minet M; Lefaucheur JP; Mick G; Piano V; Pickering G; Piquet E; Regis C; Salvat E; Attal N
Rev Neurol (Paris); 2020 May; 176(5):325-352. PubMed ID: 32276788
[TBL] [Abstract][Full Text] [Related]
14. Managing procedural pain in pediatric patients.
Cramton RE; Gruchala NE
Curr Opin Pediatr; 2012 Aug; 24(4):530-8. PubMed ID: 22732639
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapies in pediatric pain management.
Mosiman W; Pile D
J Infus Nurs; 2013; 36(2):98-106. PubMed ID: 23455971
[TBL] [Abstract][Full Text] [Related]
16. Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer.
Smith EM; Bakitas MA; Homel P; Piehl M; Kingman L; Fadul CE; Bookbinder M
J Pain Symptom Manage; 2011 Dec; 42(6):822-38. PubMed ID: 21820851
[TBL] [Abstract][Full Text] [Related]
17. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain.
Dougherty M; DeBaun MR
J Pediatr; 2003 Apr; 142(4):373-6. PubMed ID: 12712053
[TBL] [Abstract][Full Text] [Related]
18. Controversies in pharmacotherapy of pain management.
Davis MP; Walsh D; Lagman R; LeGrand SB
Lancet Oncol; 2005 Sep; 6(9):696-704. PubMed ID: 16129370
[TBL] [Abstract][Full Text] [Related]
19. Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital-based Investigation of Prevalence, Etiology, Assessment, and Treatment.
Lu F; Song L; Xie T; Tian J; Fan Y; Liu H
Pain Pract; 2017 Jan; 17(1):88-98. PubMed ID: 26991802
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]